Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...
Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.
MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback